Drug Discovery Informatics Market to Grow at 9.40% CAGR through 2029

Technological advancements in data mining and analytics and increasing R&D on drug discovery is expected to drive the Global Drug Discovery Informatics Market growth in the forecast period, 2025-2029

According to TechSci Research report, “Drug Discovery Informatics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2019-2029F”, the Global Drug Discovery Informatics Market stood at USD 3.18 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 9.40% through 2029.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Drug Discovery Informatics Market”

Market growth in the pharmaceutical and biotechnology sectors is being propelled by significant R&D investments, particularly in neglected disease research and development, as highlighted in Novartis' 2021 Annual Report. This investment, totaling approximately USD 59 million, has led to breakthroughs in managing and curing diseases previously deemed fatal. Such positive outcomes are anticipated to continue, further stimulating market expansion.

Also, data from the Congressional Budget Office reveals a substantial increase in R&D spending within the pharmaceutical industry, reaching USD 83 billion in 2019, adjusted for inflation—a tenfold surge compared to the 1980s. This heightened investment is expected to drive demand for toxicology screening services, thereby contributing to market growth.

The evolution of drug discovery informatics is closely tied to shifts in R&D investments, particularly concerning rare diseases. Advancements in in silico tools, which integrate computational workflows with drug chemistry, have significantly propelled growth in this sector. With pharmaceutical companies increasingly emphasizing cost-effective drug discovery approaches and leveraging real-time analysis software, the global drug discovery informatics market is poised for further expansion.

The market is set to benefit from increased funding for drug discovery and development by small and medium-sized pharmaceutical enterprises. Notably, in March 2022, ArrePath—a drug discovery startup—secured USD 20 million in seed funding from prominent investors, earmarked for their machine learning-based drug discovery platform aimed at combatting antimicrobial resistance. Also, technological innovations in drug discovery platforms, such as the release of TorchDrug by PyTorch in October 2021, are anticipated to drive market growth. TorchDrug, an open-source machine learning platform, promises to expedite drug discovery research and can be seamlessly integrated through PIP installation, provided PyTorch and torch-scatter are already installed. These factors collectively indicate a promising trajectory for market expansion in the foreseeable future.

The Global Drug Discovery Informatics Market is segmented into mode, workflow, services, end user, regional distribution, and company.

Based on End User, the pharmaceutical and biotechnology companies’ segment is set to experience sustained growth over the forecast period. Informatics software plays a vital role in various stages of pre-clinical research and development, including target identification, compound screening, and lead identification, thereby streamlining the drug discovery process. This growth is primarily fueled by the software's capacity to expedite drug target identification, refine drug candidate screening, and predict potential drug resistance and side effects.

Data mining software enables researchers and industry professionals to access pertinent and current data generated by the scientific community, further driving growth in this segment. Additionally, product launches by pharmaceutical companies contribute to its expansion. For instance, Curve Therapeutics Ltd. adopted the CDD Vault platform in December 2020 to manage its genetically encoded platform. This cloud-based platform facilitates secure real-time data sharing and collaborative discoveries in pharmaceutical and biotechnology applications. Pharmaceutical players employ diverse strategies to optimize the utilization of drug discovery informatics in drug design and development. Notably, in April 2022, Iktos, an Artificial Intelligence (AI) company specializing in new drug design, entered into a strategic collaboration agreement with Teijin Pharma Limited, a core company of the Teijin Group's healthcare business. Similarly, in January 2022, Shanghai Fosun Pharmaceutical (Fosun Pharma) partnered with Insilico Medicine, an AI-driven drug discovery and development company, to advance the discovery and development of drugs targeting various global targets using AI technology. These collaborations underscore the commitment of industry players to leveraging cutting-edge technologies for innovation and growth.

Based on region, North America is expected to maintain market dominance, largely attributed to the prominent presence of leading pharmaceutical companies based in the United States and Canada. This strong industry foothold has significantly propelled the growth of drug discovery informatics within the region. Additionally, the availability of cutting-edge research infrastructure, such as high-performance computing clusters, advanced imaging technologies, and state-of-the-art data storage and management systems, within renowned universities, research institutes, and government research agencies, has played a crucial role in fostering market expansion in North America. 

Major companies operating in Global Drug Discovery Informatics Market are:

• Dassault Systemes SE
• IBM Corporation
• Infosys Ltd.
• Schrödinger Inc.
• Jubilant Life Sciences NV
• Aragen Lifescience Ltd.
• Charles River Laboratories Inc.
• Thermo Fisher Scientific, Inc.
• Clarivate Analytics LLC
• PerkinElmer Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Drug discovery informatics is a rapidly evolving field that holds increasing importance in the pharmaceutical industry. By harnessing the power of data science and computer technology, researchers have the opportunity to expedite the drug discovery process, reduce costs, and ultimately develop more efficacious treatments for a wide array of diseases. The significant growth in the healthcare and pharmaceutical sectors worldwide is a key factor fostering a positive outlook for the market. Moreover, the rising prevalence of chronic medical conditions and the growing demand for effective solutions to address rare diseases are further propelling market expansion. Pharmaceutical organizations widely employ drug discovery informatics for analyzing new drug entities and managing biological information from various sources. Additionally, advancements in technology, such as the development of innovative Physiologically based Pharmacokinetic (PBPK) Simulator platforms for predicting pharmacokinetic outcomes through modeling and simulation, are acting as catalysts for growth. Furthermore, increasing investments by government and private healthcare institutions in the development of orphan drugs are also contributing to market expansion. Other factors, including the aging population and extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market forward.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Drug Discovery Informatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Mode (In-house, Outsourced), By Workflow (Discovery, Development), By Services (Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management, Others), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Drug Discovery Informatics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Drug Discovery Informatics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com